M-14003 Trichomonas Vaginalis Test Kit
Diagnostic Significance: Trichomoniasis (trichomonal vaginitis) is a common gynecological condition caused by Trichomonas vaginalis. Trichomonads are transmitted directly through sexual intercourse and can be found in the male urethra and prostate secretions. Trichomonads can parasitize not only within the vagina but also in the lower urinary tract (urethra and periurethral glands) and the cervical canal. Clinically, carriers of Trichomonas may not exhibit any symptoms. Parasitic Trichomonas in the vagina consume glycogen, alter the vaginal pH, and compromise the defense mechanisms, making secondary infections more likely.
Clinical Departments: Gynecology, Obstetrics.
Sampling Site: Collection of vaginal secretions from women.
Product Features:
- Simple, rapid, and accurate.
- High sensitivity and specificity, minimally affected by other microbes in the sample.
Comparison of Different Testing Methodologies:
- Wet Mount: Convenient and fast, requires no consumables. However, it has a lower detection rate and is prone to false negatives, especially when samples are dry or have been stored for an extended period.
- Immunofluorescence Method: Combines immunological and morphological advantages, offering a higher detection rate and the ability to produce color graphic reports.
Packaging Specifications: 50 tests per box.
Storage Conditions and Shelf Life: Store in a dark, cool place at 2-8°C, with a shelf life of 14 months.
Usage Scenarios:
- Gynecology and Obstetrics Departments: For diagnosing and monitoring trichomonal vaginitis in women.
- Hospitals and Clinics: For rapid and accurate testing of Trichomonas vaginalis, particularly in settings with a high prevalence of sexually transmitted infections.
- Diagnostic Laboratories: For routine testing of vaginal secretions to detect Trichomonas vaginalis with high sensitivity and specificity.
Suitable Countries and Regions:
- Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic tools are used to enhance patient care in gynecology and obstetrics.
- Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are expanding and improving diagnostic capabilities for sexually transmitted infections.
- Global Health Programs: International health initiatives focused on improving the diagnosis and management of trichomonal vaginitis and other sexually transmitted infections in low-resource settings.

